Author Archives: Rabita Aziz

AIDS 2018: Global health security, economic stability priorities for U.S. global TB response

By on .

AMSTERDAM – Addressing the threats that tuberculosis  poses to global health security and economic stability is the highest prioritiy in the U.S. government’s global TB response, U.S. Agency for International Development’s chief of staff William Steiger said here on Sunday. Drug-resistant forms of TB account for one in four of antimicrobial resistant infections, Steiger said, demanding […]

U.S. joins other G20 countries in antimicrobial resistance research initiative

By on .

Infectious Diseases Society of America Senior Global Health Policy Specialist Rabita Aziz sent this dispatch from the 71st World Health Assembly in Geneva, where she will deliver remarks on behalf of IDSA (which produces this blog) and other organizations, this week. GENEVA – Calling growing antimicrobial resistance “a crack in the cornerstone of modern medicine, […]

U.S. voices strong support for health security in Geneva while curtailing support in Washington

By on .

Infectious Diseases Society of America Senior Global Health Policy Specialist Rabita Aziz sent this dispatch from the 71st World Health Assembly in Geneva, where she will deliver remarks on behalf of IDSA (which produces this blog) and other organizations, this week. GENEVA – The U.S. will contribute an additional $7 million on top of a […]

Spending bill boosts NIH, USAID TB, lifts Fogarty, flatlines PEPFAR, Global Fund

By on .

The spending bill for 2018 passed in the House Thursday, and the Senate early today has delivered a robust rejection of the President’s proposals to slash science spending while massively cutting funds for global infectious disease responses, with a combination of level funding and a few notable raises. They include with a $3 billion boost for […]

Study shows revaccination with existing TB vaccine prevents TB infection later in life

By on .

Getting revaccinated later in life with the same vaccine given to infants to prevent tuberculosis may provide additional protection after the original vaccine loses efficacy, researchers at the 5th Global Forum on TB Vaccines in New Delhi, India, revealed. The Bacillus Calmette–Guérin, or BCG, vaccine is partially effective against preventing TB infection in children for […]

WHO Executive Board Meeting: HHS Global Affairs leader cites need to increase investments in worldwide health emergency preparedness

By on .

GENEVA – Staff from the U.S. Department of Health and Human Services Office of Global Affairs, the Centers for Disease Control and Prevention, and USAID made it here despite the current U.S. government office shutdown, and are participating in the 142nd World Health Organization Executive Board session, which kicked off today at WHO headquarters in […]

Report shows 1 in 10 medicines in low-and middle income countries are substandard, falsified

By on .

Antibiotics and antimalarial drugs are most frequently reported as substandard and falsified to the World Health Organization’s Global Surveillance and Monitoring system for such medical products, according to a WHO report released this week. The report estimates that one in ten medical products in low- and middle-income countries either fail to meet quality standards or […]

Study reveals biological processes leading to active tuberculosis disease

By on .

Researchers at the University of Cape Town in South Africa have identified a sequence of biological processes that occur as tuberculosis infection progresses to active pulmonary tuberculosis disease. The findings, which demonstrate a clear timeline of biological events that occur between infection and disease, hold important implications for the development of new diagnostics, treatments, and […]